<?xml version="1.0" encoding="UTF-8"?>
<messages xmlns="https://www.news.admin.ch/messages" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" version="1.0">
  <message id="77414" revoked="no">
    <version>1</version>
    <pubdate>2019-12-06</pubdate>
    <type>Memorandum</type>
    <originator department-msg="no" id="1070" lead="yes" topnews="no">
      <department-id>1070</department-id>
      <name lang="de">Der Bundesrat</name>
      <name lang="fr">Conseil fédéral</name>
      <name lang="it">Il Consiglio federale</name>
      <name lang="en">The Federal Council</name>
      <www lang="de">https://www.admin.ch/gov/de/start.html</www>
      <www lang="fr">https://www.admin.ch/gov/fr/accueil.html</www>
      <www lang="it">https://www.admin.ch/gov/it/pagina-iniziale.html</www>
      <www lang="en">https://www.admin.ch/gov/en/start.html</www>
      <email lang="de">info@bk.admin.ch</email>
      <email lang="fr">info@bk.admin.ch</email>
      <email lang="it">info@bk.admin.ch</email>
      <email lang="en">info@bk.admin.ch</email>
    </originator>
    <originator department-msg="no" id="302" lead="no" topnews="no">
      <department-id>301</department-id>
      <name lang="de">Generalsekretariat EDI</name>
      <name lang="fr">Secrétariat général DFI</name>
      <name lang="it">Segreteria generale DFI</name>
      <name lang="en">General Secretariat FDHA</name>
      <www lang="de">http://www.edi.admin.ch</www>
      <www lang="fr">http://www.edi.admin.ch</www>
      <www lang="it">http://www.edi.admin.ch</www>
      <www lang="en">http://www.edi.admin.ch</www>
      <email lang="de">info@gs-edi.admin.ch</email>
      <email lang="fr">info@gs-edi.admin.ch</email>
      <email lang="it">info@gs-edi.admin.ch</email>
      <email lang="en">info@gs-edi.admin.ch</email>
    </originator>
    <originator department-msg="no" id="324" lead="no" topnews="no">
      <department-id>301</department-id>
      <name lang="de">Swissmedic, Schweizerisches Heilmittelinstitut</name>
      <name lang="fr">Swissmedic, Institut suisse des produits thérapeutiques</name>
      <name lang="it">Swissmedic, Istituto svizzero per gli agenti terapeutici</name>
      <name lang="en">Swiss Agency for Therapeutic Products</name>
      <www lang="de">http://www.swissmedic.ch/</www>
      <www lang="fr">http://www.swissmedic.ch/?lang=3</www>
      <www lang="it">http://www.swissmedic.ch/?lang=4</www>
      <www lang="en">http://www.swissmedic.ch/?lang=2</www>
      <email lang="de"/>
      <email lang="fr"/>
      <email lang="it"/>
      <email lang="en"/>
    </originator>
    <department id="1070">
      <name lang="de">Der Bundesrat</name>
      <name lang="fr">Conseil fédéral</name>
      <name lang="it">Il Consiglio federale</name>
      <name lang="en">The Federal Council</name>
      <www lang="de">https://www.admin.ch/gov/de/start.html</www>
      <www lang="fr">https://www.admin.ch/gov/fr/accueil.html</www>
      <www lang="it">https://www.admin.ch/gov/it/pagina-iniziale.html</www>
      <www lang="en">https://www.admin.ch/gov/en/start.html</www>
      <email lang="de">info@bk.admin.ch</email>
      <email lang="fr">info@bk.admin.ch</email>
      <email lang="it">info@bk.admin.ch</email>
      <email lang="en">info@bk.admin.ch</email>
    </department>
    <department id="301">
      <name lang="de">Eidgenössisches Departement des Innern</name>
      <name lang="fr">Département fédéral de l'intérieur</name>
      <name lang="it">Dipartimento federale dell'interno</name>
      <name lang="en">Federal Department of Home Affairs</name>
      <www lang="de">http://www.edi.admin.ch</www>
      <www lang="fr">http://www.edi.admin.ch</www>
      <www lang="it">http://www.edi.admin.ch</www>
      <www lang="en">http://www.edi.admin.ch</www>
      <email lang="de">info@gs-edi.admin.ch</email>
      <email lang="fr">info@gs-edi.admin.ch</email>
      <email lang="it">info@gs-edi.admin.ch</email>
      <email lang="en">info@gs-edi.admin.ch</email>
    </department>
    <content lang="de">
      <city>Bern</city>
      <title>Publikationshinweis</title>
      <lead>Depakine-Skandal. Untersuchung der Situation in der Schweiz. </lead>
      <text link="no">Der Bundesrat hat an seiner Sitzung vom 6. Dezember 2019 den Bericht in Erfüllung des Postulates 18.3092 Maury Pasquier vom 07. März 2018 verabschiedet.&lt;br /&gt; </text>
      <contact>Swissmedic, Giorgio Poma, +41 58 469 20 86, giorgio.poma@swissmedic.ch</contact>
      <attachment id="196079">
        <title>Bericht</title>
        <format>pdf</format>
        <size-kb>1003</size-kb>
        <uri>https://www.newsd.admin.ch/newsd/message/attachments/59458.pdf</uri>
        <position>Content</position>
      </attachment>
      <link id="196076">
        <title>Ausgewählte Themen zur Patientensicherheit</title>
        <uri>https://www.swissmedic.ch/swissmedic/de/home/humanarzneimittel/marktueberwachung/fokusthemen.html</uri>
        <position>Content</position>
      </link>
      <revisions> </revisions>
    </content>
    <content lang="fr">
      <city>Berne</city>
      <title>Avis de publication</title>
      <lead>Scandale de la Dépakine. Analyse de la situation en Suisse.</lead>
      <text link="no">&lt;p&gt;Lors de sa séance du 6 décembre 2019, le Conseil fédéral a adopté le rapport en réponse au postulat 18.3092 Maury Pasquier du 7 mars 2018.&lt;/p&gt;</text>
      <contact>Swissmedic, Giorgio Poma, +41 58 469 20 86, giorgio.poma@swissmedic.ch</contact>
      <attachment id="196080">
        <title>Rapport</title>
        <format>pdf</format>
        <size-kb>1004</size-kb>
        <uri>https://www.newsd.admin.ch/newsd/message/attachments/59459.pdf</uri>
        <position>Content</position>
      </attachment>
      <link id="196077">
        <title>Sujets sélectionnés sur la sécurité des patients</title>
        <uri>https://www.swissmedic.ch/swissmedic/fr/home/medicaments-a-usage-humain/surveillance-du-marche/fokusthemen.html</uri>
        <position>Content</position>
      </link>
      <revisions> </revisions>
    </content>
    <content lang="it">
      <city>Berna</city>
      <title>Avviso di pubblicazione</title>
      <lead>Scandalo Depakin. Analisi della situazione in Svizzera</lead>
      <text link="no">&lt;p&gt;Durante la seduta del 6 dicembre 2019, il Consiglio federale ha adottato il rapporto in adempimento del postulato 18.3092 Maury Pasquier del 7 marzo 2018.&lt;/p&gt;</text>
      <contact>Swissmedic, Giorgio Poma, +41 58 469 20 86, giorgio.poma@swissmedic.ch</contact>
      <attachment id="196081">
        <title>Rapporto (Fra)</title>
        <format>pdf</format>
        <size-kb>1004</size-kb>
        <uri>https://www.newsd.admin.ch/newsd/message/attachments/59460.pdf</uri>
        <position>Content</position>
      </attachment>
      <link id="196078">
        <title>Priorità tematiche in materia di sicurezza dei pazienti</title>
        <uri>https://www.swissmedic.ch/swissmedic/it/home/medicamenti-per-uso-umano/sorveglianza-del-mercato/fokusthemen.html</uri>
        <position>Content</position>
      </link>
      <revisions> </revisions>
    </content>
    <topics>
      <topic id="5">
        <name lang="de">Behörden</name>
        <name lang="fr">Autorités</name>
        <name lang="it">Autorità</name>
        <name lang="en">Authorities</name>
      </topic>
      <topic id="10">
        <name lang="de">Bundesrat</name>
        <name lang="fr">Conseil fédéral</name>
        <name lang="it">Consiglio federale</name>
        <name lang="en">Federal Council</name>
      </topic>
    </topics>
  </message>
</messages>
